Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,676.00
Bid: 1,672.40
Ask: 1,672.80
Change: 0.00 (0.00%)
Spread: 0.40 (0.02%)
Open: 1,679.60
High: 1,686.40
Low: 1,667.80
Yest. Close: 1,685.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LONDON MARKET PRE-OPEN: Smiths Finds Medical CEO; Ferrexpo Improves

Fri, 7th Jun 2019 07:36

LONDON (Alliance News) - Stock prices in London are set to open higher Friday after a disappointing finish Thursday as the European Central Bank failed to boost sentiment.In London, FTSE 100-listed firm Smiths Group named a new chief executive for its planned spin-off Smiths Medical, as Ferrexpo said its earnings in the first half of the year will be "materially" higher than the year before. Games Workshop said it expects to see both profit and sales growth in financial 2019. IG futures indicate the FTSE 100 is set to open 13.55 points higher at 7,273.40. The blue chip index closed up 39.63 points, or 0.6%, at 7,259.85 on Thursday.On Thursday, In Paris the CAC 40 ended down 0.3%, while the DAX 30 in Frankfurt ended down 0.2%."Eurozone stocks largely finished lower yesterday on the back of the update from the European Central Bank. Interest rates were kept on hold, which met traders' expectations, but the update from Mario Draghi, the head of the ECB, wasn't the dovish update that many were expecting," commented CMC Market analyst David Madden.The ECB kept interest rates on the main refinancing operations, on the marginal lending facility, and on the deposit facility were kept at 0.00%, 0.25% and minus 0.40%, respectively. These rates have been at record lows following the eurozone debt crisis of 2011 in an bid to boost inflation and stimulate growth.The ECB now expects GDP growth of 2.1% in 2019 and 1.4% for both 2020 and 2021. This compares with the central bank's March forecast of 2.0% growth in 2019, and 1.6% and 1.5% for 2020 and 2021 respectively.For the harmonised index of consumer prices, the ECB forecasts 1.3%, 1.4% and 1.6% growth for 2019, 2020 and 2021 respectively. This compares with 1.2%, 1.5% and 1.6% for 2019, 2020 and 2021 respectively predicted in March.In early corporate news, pharma firm GlaxoSmithKline said the US Food & Drug Administration has approved two new methods for administering Nucalaan, autoinjector and a pre-filled safety syringe, for patients to administer once every four weeks.GSK Chief Scientific Officer Hal Barron said: "Nucala's efficacy is well-established and this approval means that, for the first time, we are able to provide patients living with these debilitating conditions the option of receiving this important medicine in their own home."Smiths Group has named JehanZeb Noor as CEO of its soon-to-be demerged Smiths Medical. Noor will take up the role on July 1 to oversee the separation - which is expected in the first half of 2020. In November, the engineering firm announced the spin-out its struggling medical unit. Smiths Medical will separately list in the UK. Ferrexpo said its group earnings before interest, tax, depreciation and amortization is expected to "increase materially" in the first half compared to the year before.The company said the year to date improvement in profitability has been driven by higher pricing, production and sales volumes. Ferrexpo also announced it has hired former Ernst Young partner Graeme Dacomb to join its board and the Independent Review Committee which is looking into matters relating to Blooming Land. Ferrexpo's auditor, Deloitte, quit with immediate effect at the end of April amid an investigation into payments made by Ferrexpo into Ukrainian charity Blooming Land. Deloitte noted, as reasons for resigning, Ferrexpo's refusal in January to set up a forensic investigation into the matter. At the end of that month, Deloitte said that if Ferrexpo did not do so it would be forced to consider its position as auditor. Games Workshop said it has seen sales growth across all of its channels in financial 2019, resulting in profit growth.Games Workshop expects sales for the year ended June 2 to be about GBP254 million and the company's pretax profit to be "not less than" GBP80 million.The company paid a total dividend of GBP1.55 per share in the period compared to GBP1.26 per share the year before. Elsewhere, life insurance consolidator ReAssure Group said it is considering an initial public offering of shares in London. The firm is a closed-book life insurance consolidator in the UK with 4.3 million policies and GBP68.7 billion of assets under administration. ReAssure is the sixth largest life insurance group in the UK.This afternoon, market focus will turn to the release of US nonfarm payrolls at 1330 BST.In the US on Thursday, Wall Street ended higher, with the Dow Jones Industrial Average ending up 0.7%, the S&P 500 up 0.6% and Nasdaq Composite closing 0.5% higher.CMC's Madden said: "US equity markets finished higher as US-Mexican trade discussions are heading in the right direction. President Trump threatened to impose 5% tariffs on all imports from Mexico unless the country tightens its border with the US. Mexico's ambassador to the US, Martha Barcena Coqui, said that negotiators had a 'very good debate', and that boosted US stocks, but Vice President, Mike Pence, claims the tariffs will still come in effect on Monday. Investors are hoping the measures the Mexican government are taking will be enough to prevent the levies from being introduced."Mexico and the US reported progress in their talks on illegal migration on Thursday, but Washington said it was not yet sufficient to prevent US President Donald Trump from slapping a tariff on all Mexican imports."I think that progress is being made," said Mexico's Secretary of Foreign Affairs Marcelo Ebrard, who heads the country's delegation to Washington."However we don't have a deal, but we have presented our point of view. Tomorrow we will have another round [of talks]," Ebrard told journalists at the end of Thursday's talks.Ebrard added that his delegation had informed the US that Mexico approved the deployment of 6,000 National Guard troops to coordinate his country's southern border.Trump earlier in the day had tweeted that progress was being made, "but not nearly enough!".Sterling was quoted at USD1.2702 early Friday, lower than USD1.2721 at the London equities close on Thursday.In the UK, Theresa May will formally stand down as Tory leader on Friday - although she will carry on as prime minister and acting party leader until a successor is in place.May will confirm her decision in an exchange of letters with the joint acting chairmen of the backbench 1922 Committee, Charles Walker and Cheryl Gillan.Under the timetable set out by the party high command, it is expected the new leader will be in place in the week beginning July 22 following a postal ballot of the party's 120,000 grassroots members.May is preparing to step down amid a growing row with Chancellor Philip Hammond over her plans to leave with a series of big spending announcements - including a multi-billion pound overhaul of England's schools and colleges - according to the Financial Times.In Asia on Friday, the Japanese Nikkei 225 index closed up 0.6%. In China, the Shanghai Composite and Hang Seng index in Hong Kong were both closed for the Dragon Boat festival.The economic events calendar on Friday has UK Halifax house prices at 0830 BST.

More News

Glaxo's ViiV Reports Positive Study Results Of HIV-Treatment Regimen

(Alliance News) - GlaxoSmithKline PLC on Thursday said ViiV Healthcare reported positive headline results from its global phase III ATLAS-2M study.ViiV Healthcare is a specialist HIV owned

22 Aug 19 08:20

GlaxoSmithKline upbeat on latest test results from ViiV Healthcare

(Sharecast News) - GlaxoSmithKline reported on Thursday that its specialist HIV company ViiV Healthcare had announced positive headline results from its phase 3 'ATLAS-2M' study of the investigational, long-acting, injectable, two-drug regimen (2DR) of its cabotegravir and Janssen's rilpivirine for the treatment of HIV.

22 Aug 19 07:29

Glaxo Submits Japanese Application For Daprodustat Anaemia Drug

(Alliance News) - GlaxoSmithKline PLC on Wednesday said it has submitted a new drug application in Japan for anaemia drug daprodustat.The application was submitted to the Japanese Ministry

21 Aug 19 08:38

GlaxoSmithKline seeking marketing approval for 'daprodustat' in Japan

(Sharecast News) - GlaxoSmithKline announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare on Wednesday, seeking marketing approval for 'daprodustat'.

21 Aug 19 08:07

WINNERS & LOSERS SUMMARY: Plus500 Up On Share Buyback, New Customers

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------TUI, up

13 Aug 19 10:09

LONDON MARKET OPEN: TUI And Plus500 Both Rise Despite Profit Falls

(Alliance News) - Stock prices in London opened lower on Tuesday as concerns about the US-China trade war, protests in Hong Kong, and fears of a global economic slowdown continue to sap sentiment.

13 Aug 19 08:43

Glaxo US Pharma Head To Leave Role, Poaches Merck KGaA Oncology Head

(Alliance News) - GlaxoSmithKline PLC said on Monday that the head of its US pharmaceuticals division Jack Bailey will step down at the end of the year and will be replaced by Merck KGaA's the

12 Aug 19 17:00

MidaTech Pharma Appoints Frederic Duchesne As Non-Executive Director

(Alliance News) - Midatech Pharma PLC said Wednesday that Frederic Duchesne had been appointed as a non-executive director, effective immediately.Duchesne was chief executive of the of May.

31 Jul 19 15:54

GlaxoSmithKline Notes Positive Tango And Gemini HIV Study Results

(Alliance News) - GlaxoSmithKline PLC on Wednesday noted positive results from the Gemini and Tango phase three studies of a dolutegravir plus lamivudine in HIV patients.The results were by

24 Jul 19 17:20

TOP NEWS: GlaxoSmithKline Profit Up In First Half; Guidance Improved

(Alliance News) - GlaxoSmithKline PLC on Wednesday said its profit rose almost 50% in the first half of the year due to strong performances from its Vaccines and Consumer Healthcare also upgraded

24 Jul 19 12:35

LONDON MARKET MIDDAY: Miners Press FTSE Deeper Into Red On Vale News

(Alliance News) - Miners put the FTSE 100 under pressure on Wednesday while the FTSE 250 battled to stay in the green in the face of a 24% slump for luxury car maker Aston large-cap FTSE a

24 Jul 19 11:53

TOP NEWS: GlaxoSmithKline Hires Ex-Astra Finance Boss Symonds As Chair

(Alliance News) - GlaxoSmithKline PLC said Wednesday former AstraZeneca PLC finance chief Jonathan Symonds will replace outgoing Chair Philip Hampton at the FTSE 100-listed drugmaker from the of a

24 Jul 19 10:34

GlaxoSmithKline's ViiV Healthcare Gets Positive Fostemsavir Results

(Alliance News) - GlaxoSmithKline PLC on Monday said its ViiV Healthcare has seen positive results from the phase three Brighte study of investigational fostemsavir in heavily adults with is HIV a

22 Jul 19 17:19

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 18 July Scieifitic Digital Imaging Half Year ResultsAudioboomHalf Year Year

17 Jul 19 16:07

Mereo BioPharma Names Richard Francis As New Pharmaceutical Head

(Alliance News) - Mereo BioPharma has appointed Richard Francis as the new head of pharmaceutical development, effective August 1, the biopharmaceutical company said on Tuesday.Francis was

16 Jul 19 14:46

Login to your account

Don't have an account? Click here to register.